Key Details
Price
$0.86Annual ROE
-86.42%Beta
-0.03Events Calendar
Next earnings date:
Jan 03, 2025Recent quarterly earnings:
Oct 02, 2024Recent annual earnings:
Oct 02, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
LUXEMBOURG / ACCESSWIRE / October 16, 2024 / Moolec Science SA (NASDAQ:MLEC) ("the Company"), a leader in Molecular Farming technology, announced today that the U.S. Department of Agriculture's ("USDA") Animal and Plant Health Inspection Service ("APHIS") has completed its Regulatory Status Review ("RSR") for the Company's genetically engineered ("GE") peas which produce iron through bovine meat proteins. This is the third regulatory clearance from USDA-APHIS achieved by Moolec in an 18-month window, alongside its genetically engineered safflower and soybean for GLASO™ and Piggy Sooy™ products, respectively.
LUXEMBOURG / ACCESSWIRE / October 2, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today reported its Business Update for the fourth quarter of Fiscal Year 2024 ended June 30, 2024. Moolec Science Logo The main highlights of Moolec's fourth quarter are as follows: GLASO™: The Company announced an offtake agreement with a major global CPG food and pet food company and an R&D collaboration agreement with Bunge.
Moolec Science SA (NASDAQ:MLEC ) Q4 2024 Earnings Conference Call October 2, 2024 8:30 AM ET Company Participants Gaston Paladini - Chief Executive Officer Jose Lopez Lecube - Chief Financial Officer Martin Salinas - Chief Technology Officer Amit Dhingra - Chief Science Officer Bill Zima - ICR Strategic Communications Conference Call Participants Scott Fortune - Roth Capital Operator Good morning and welcome to Moolec Science's fourth quarter and full fiscal year 2024 conference call. My name is Bill Zima of ICR Strategic Communications and Advisory.
LUXEMBOURG / ACCESSWIRE / September 25, 2024 / Moolec Science SA (NASDAQ:MLEC)("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, announced today that it will release its Business Update for the Fourth Quarter and Full Fiscal Year 2024 on Wednesday, October 2, 2024, before the market opens. Moolec Sciences Logo Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, and Chief Science Officer Amit Dhingra, will host a live Conference Call, followed by a question-and-answer session, on Wednesday, October 2, 2024 at 08:30am ET.
LUXEMBOURG / ACCESSWIRE / September 5, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company", "Moolec"), a science-based food ingredient company, announced today the harvest confirmation of US campaigns for genetically engineered plant-grown products GLASO™ and Piggy Sooy™ during October 2024. GLASO™ and Piggy Sooy™ US Harvest Announcement GLASO™ (gamma-linolenic acid -GLA- in safflower oil) campaign located in Idaho consists of 600 planted acres of genetically modified safflower, mainly for commercial purposes.
LUXEMBOURG / ACCESSWIRE / March 6, 2024 / Moolec Science SA (NASDAQ:MLEC) ("Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today that it will release its Business Update for the Second Quarter Fiscal Year 2024 on Wednesday, March 13, 2024, before the market opens. logo Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, and Chief Science Officer Amit Dhingra will host a live Conference Call on Wednesday, March 13, 2024, at 08:30 am ET.
Moolec Science SA (MLEC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Moolec Science (NASDAQ: MLEC ) stock is getting a boost on Thursday despite a lack of news from the science-based food ingredient company. There are no new press releases or filings with the Securities and Exchange Commission (SEC) that explain why the stock is rising today.
LUXEMBOURG / ACCESSWIRE / December 7, 2023 / Moolec Science SA (NASDAQ:MLEC)("Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today that it will release its Business Update for the First Quarter Fiscal Year 2024 on Thursday, December 14, 2023, before the market opens. MLEC Logo Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, and Chief Science Officer Amit Dhingra will host a live Conference Call, followed by a question-and-answer session, on Thursday, December 14, 2023, at 08:30am ET.
Moolec Science SA (NASDAQ:MLEC ) Q1 2023 Earnings Conference Call May 31, 2023 8:00 AM ET Company Participants Martín Taraciuk - Head, IR Gaston Paladini - Co-Founder, CEO & Director Amit Dhingra - Chief Science Officer Jose Lopez Lecube - CFO & Director Conference Call Participants Martín Taraciuk Good morning, and welcome to Moolec's conference call. My name is Martín Taraciuk, and I'm Moolec's Head of Investor Relations.
FAQ
- What is the primary business of Moolec Science SA?
- What is the ticker symbol for Moolec Science SA?
- Does Moolec Science SA pay dividends?
- What sector is Moolec Science SA in?
- What industry is Moolec Science SA in?
- What country is Moolec Science SA based in?
- When did Moolec Science SA go public?
- Is Moolec Science SA in the S&P 500?
- Is Moolec Science SA in the NASDAQ 100?
- Is Moolec Science SA in the Dow Jones?
- When was Moolec Science SA's last earnings report?
- When does Moolec Science SA report earnings?
- Should I buy Moolec Science SA stock now?